Routine Screening for Eosinophilic Esophagitis in Patients Presenting With Dysphagia
NCT ID: NCT01028235
Last Updated: 2009-12-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2006-01-31
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Obstructive Dysphagia
Patients who complained of dysphagia, which had an obstructive etiology for their symptoms at the time of endoscopy (ring, mass, stricture, etc)
No interventions assigned to this group
Non-obstructive Dysphagia
Patients whose endoscopy was normal and without any obvious etiology for their symptoms noted.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* complaint of dysphagia
Exclusion Criteria
* age \<18
* on inhaled steroids within the last 30 days
* on systemic steroids in the last 30 days
* known diagnosis of Eosinophilic Esophagitis
* obvious obstructive etiology found at endoscopy
* increased risk of bleeding (on blood thinners or anti-platelet agents other than aspirin)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
San Antonio Uniformed Services Health Education Consortium
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
SAUSHEC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonathan M Ricker, DO
Role: PRINCIPAL_INVESTIGATOR
San Antonio Uniformed Services Health Education Consortium
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wilford Hall Medical Center
San Antonio, Texas, United States
Brooke Army Medical Center
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jonathan M Ricker, DO
Role: primary
Kevin J Franklin, MD
Role: backup
Scott McNear, DO
Role: primary
Hays Arnold, MD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FWH20060112H
Identifier Type: -
Identifier Source: org_study_id